Point72 Asia (Singapore)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$481K Sell
4,926
-504
-9% -$52.2K 0.07% 172
2025
Q2
$583K Buy
5,430
+5,392
+14,189% +$546K 0.1% 183
2025
Q1
$3.83K Buy
+38
New +$3.83K ﹤0.01% 788
2024
Q4
Sell
-5,229
Closed -$438K 892
2024
Q3
$438K Buy
+5,229
New +$412K 0.08% 199

Other funds holding BSX

Point72 Asia (Singapore)'s BSX Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Boston Scientific (BSX) stake by 9.3% in Q3 2025, selling an estimated $52.2K and leaving 4,926 shares worth $481K. The position accounts for 0.07% of the portfolio, ranked #172.

Point72 Asia (Singapore) first reported a position in BSX in Q3 2024 and has held it in 4 quarters since. The position peaked at $583K in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Point72 Asia (Singapore) held 4,926 shares of Boston Scientific worth $481K as of Q3 2025.
  • Point72 Asia (Singapore) sold 504 Boston Scientific shares in Q3 2025, an estimated $52.2K.
  • Boston Scientific made up 0.07% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #172 holding.
  • Point72 Asia (Singapore) first reported a position in Boston Scientific in Q3 2024 and has held it in 4 quarters since.
  • Point72 Asia (Singapore)'s Boston Scientific position peaked at $583K in Q2 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.